The presentation of TIA-like symptoms, the role of MRI in diagnosis, and the subsequent genetic confirmation through NOTCH3 testing all align with the broader understanding of CADASIL in the literature [10]. The gene discussed is NOTCH3; the disease is transient ischemic attack.